The dense, fibrous stroma of the ECM surrounding tumor islets hinders cancer chemotherapy, and recent research has shown that cancer chemotherapy combined with pharmacologic FAK inhibitors can increase responsiveness to chemotherapy and immunotherapy by lowering the stromal density in various solid cancers [157]. The gene discussed is PTK2; the disease is cancer.